All charts and data below are CPI-U inflation-adjusted and with dividends reinvested. (Why?)
GSK real return snapshot: after CPI-U inflation, GSK returned +31.83% over the past year and +3.47% YTD, with dividends reinvested. Since Mar. 28, 1980, GSK is up +11,012.23% in real purchasing-power return, or +10.75%/yr, and is currently −99.99% below its real total-return high on Sep. 27, 1985.
| Fri 1980-03-28? to Fri 2026-05-22 |
YTD
Return |
1 Year
Return |
||||
|---|---|---|---|---|---|---|
| GSK × |
+3.47%
2026-05-22 |
+31.83%
2026-05-22 |
||||
| GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||
| Fri 1980-03-28? to Fri 2026-05-22 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| GSK × |
+11,012.23%
+10.75%/yr |
+7.66%/yr
(R2=0.691) |
||||
| GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||
| Fri 1980-03-28? to Fri 2026-05-22 |
Start
Value |
End
Value |
||||
|---|---|---|---|---|---|---|
| GSK × |
$10,000.00
1980-03-28 |
$1,111,223.27
2026-05-22 |
||||
| GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||
| Year | GSK |
|---|---|
| 2026 (YTD) | +3.47% |
| 2025 | +47.29% |
| 2024 | −7.80% |
| 2023 | +6.16% |
| 2022 | −21.82% |
| 2021 | +18.43% |
| 2020 | −18.81% |
| 2019 | +26.35% |
| 2018 | +11.66% |
| 2017 | −4.99% |
| 2016 | +0.02% |
| 2015 | −0.99% |
| 2014 | −16.32% |
| 2013 | +27.01% |
| 2012 | −1.06% |
| 2011 | +19.07% |
| 2010 | −3.57% |
| 2009 | +16.17% |
| 2008 | −22.33% |
| 2007 | −4.68% |
| 2006 | +5.29% |
| 2005 | +6.23% |
| 2004 | +2.28% |
| 2003 | +26.37% |
| 2002 | −23.41% |
| 2001 | −11.01% |
| 2000 | +0.74% |
| 1999 | −20.07% |
| 1998 | +45.83% |
| 1997 | +53.25% |
| 1996 | +14.13% |
| 1995 | +41.70% |
| 1994 | +0.39% |
| 1993 | −12.83% |
| 1992 | −25.08% |
| 1991 | +93.02% |
| 1990 | +22.93% |
| 1989 | +32.56% |
| 1988 | +2.46% |
| 1987 | +15.85% |
| 1986 | +42.43% |
| 1985 | +80.35% |
| 1984 | +26.19% |
| 1983 | −5.42% |
| 1982 | +149.25% |
| 1981 | +15.67% |
| 1980 | +15.85% |
| Fri 1980-03-28? to Fri 2026-05-22 |
Current
Drawdown |
Worst
Drawdown |
||||
|---|---|---|---|---|---|---|
| GSK × |
−99.99%
from 1985-09-27 peak |
−100.00%
1985-09-30 from 1985-09-27 peak |
||||
| GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||
| Period ending Fri 2026-05-22 |
1
Year |
2
Years |
3
Years |
5
Years |
10
Years |
|
|---|---|---|---|---|---|---|
| GSK × | +31.83% |
+14.34% +6.93%/yr |
+48.94% +14.20%/yr |
+30.73% +5.50%/yr |
+40.10% +3.43%/yr |
|
| GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||